Imagine a future where eating out is possible.

With your help we can get closer to this goal.

 

Contribute to research on a new investigational medication for celiac disease with minimal compromises to your life - no added gluten, no biopsies.

The Solutions for Celiac Study

Welcome to the Solutions for Celiac Study website. 

 

This NIH-funded clinical research study has been designed to assess the drink-based investigational medication latiglutenase and its ability to relieve common symptoms suffered by celiac disease patients after accidental gluten exposure in a real-world setting.

The Solutions for Celiac Study has been designed to be as non-intrusive on your life as possible; requiring no purposeful gluten challenge regimen and no mandatory endoscopy with biopsy procedures.

Celiac disease is an autoimmune disorder that damages the villi of the small intestine upon ingestion of gluten and can lead to a variety of gastrointestinal and non-gastrointestinal symptoms and effects.

Clinical trials are a crucial aspect of clinical research and involve the participation of volunteers to help find new methods of prevention, detection, and treatment of disease.

Find out more on our FAQ page.

The Solutions for Celiac trial is focused on investigating real-world symptom relief of a drink-based investigational medication called latiglutenase. The trial involves no intentional exposure to gluten nor any biopsies.

What is Celiac Disease?

Clinical Trials

Solutions for Celiac Trial

Share information about the Solutions for Celiac Study

©2020 by ImmunogenX